GRIFOLS | GRF - Ebitda


GRIFOLS reported EUR473M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Alcon AG USD 795M 478M Mar/2026
Almirall EUR 114.07M 60.37M Dec/2025
Amadeus IT EUR 672.8M 11.4M Jun/2026
Amarin USD 12.54M 28.57M Jun/2025
argenx SE USD 427M 22.88M Mar/2026
AstraZeneca USD 5.16B 510M Jun/2026
Bayer EUR 2.14B 2.31B Jun/2026
Cie Automotive EUR 345.96M 35.96M Dec/2024
Demant DKK 2.8B 47M Jun/2026
Ence Energia y Celulosa EUR 4.2M 8.6M Mar/2026
Essilor EUR 4.34B 1.25B Jun/2026
Ferrovial EUR 294M 248M Jun/2026
Fresenius EUR 988M 37M Jun/2026
Fresenius Medical Care EUR 843.66M 19.66M Jun/2026
Genmab DKK 401M 186M Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 473M 120M Jun/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Inditex EUR 2.57B 397M Mar/2026
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Merck EUR 1.6B 69M Jun/2026
Novartis USD 6.48B 1.19B Jun/2026
Philips EUR 910M 343M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.6B 570M Dec/2025
Viscofan EUR 71.1M 7.72M Jun/2026